WOUND TREATMENT AGENT
PROBLEM TO BE SOLVED: To provide a novel wound treatment agent with high wound healing facilitatory effect, and to provide a producing method thereof.SOLUTION: A wound treatment agent with paramylum derived from Euglena as an active ingredient is a therapeutic agent for wounds which is in a healing...
Gespeichert in:
| Hauptverfasser: | , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; jpn |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| Zusammenfassung: | PROBLEM TO BE SOLVED: To provide a novel wound treatment agent with high wound healing facilitatory effect, and to provide a producing method thereof.SOLUTION: A wound treatment agent with paramylum derived from Euglena as an active ingredient is a therapeutic agent for wounds which is in a healing process including a duration from immediately after wounded to inflammation phase. It promotes a bulge of derma around the wound in the wound healing process and promotes formation of derma around the wound, and promotes cytokine secretion in the wound healing process. And, it is used as a wound treatment agent for diabetics.
【課題】創傷の治癒促進効果の高い新規な創傷治療剤及びその製造方法を提供する。【解決手段】ユーグレナ由来のパラミロンを有効成分とする創傷治療剤であって、受傷直後から炎症期までの期間を含む治癒過程にある創傷用の治療剤である。創傷の治癒過程における前記創傷の周囲の真皮の盛り上がりを促進して、前記創傷の周囲の真皮の形成を促進し、創傷の治癒過程におけるサイトカイン分泌を促進する。また、糖尿病患者用創傷治療剤として用いられる。【選択図】図５ |
|---|